Healthcare -
Biotechnology - NASDAQ - US
$ 19.07
-7.43 %
$ 3.24 B
Market Cap
-7.28
P/E
IMVT - CASH & EQUIVALENTS
Cash & Equivalents IMVT - Immunovant, Inc.
635 M
LAST VALUE
13.43%
2 YEAR CAGR
355.23%
5 YEAR CAGR
0.00%
10 YEAR CAGR